MedTrace Logo

Aerosure and Six Minute Walk Distance in Severe COPD

NCT02007590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2018-01-11

No results posted yet for this study

Summary

To investigate whether high frequency airflow oscillation (HFAO), delivered using Aerosure, increases six minute walk distance (6MWD) and reduces exertional breathlessness in patients with severe chronic obstructive pulmonary disease (COPD).

Conditions

Interventions

DEVICE

Aerosure 25 Hz

Active Aerosure device

DEVICE

Aerosure Sham

Device designed to appear identical to active device but with HFAO mechanism disabled

Sponsors & Collaborators

  • Actegy Ltd.

    lead INDUSTRY

Principal Investigators

  • John Moxham, MD · King's College Hospital NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02007590 on ClinicalTrials.gov